SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of United Therapeutics Corporation (UTHR)

NEW YORK, July 27, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQ: UTHR). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/uthr.

The investigation concerns whether United Therapeutics and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On July 27, 2017, United Therapeutics revealed that it recorded a $210 million accrual relating to a potential settlement in connection with a U.S. Department of Justice investigation into the its possible violations of the Federal Anti-Kickback Statute and the Federal False Claims Act.  Following this news, United Therapeutic stock has dropped as much as $8.35 per share, or 6.35%, during intraday trading on July 27, 2017.

If you are aware of any facts relating to this investigation, or purchased shares of United Therapeutics, you can assist this investigation by visiting the firm's site: www.bgandg.com/uthr.  You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-united-therapeutics-corporation-uthr-300495741.html

SOURCE Bronstein, Gewirtz & Grossman, LLC